✦ LIBER ✦

Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

✍ Scribed by Carolyn F. Deacon; Jens J. Holst

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dipeptidyl peptidase inhibitors as new d

✍ H.-J. Mest; R. Mentlein 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 119 KB

Glucose-lowering activity of the dipepti

✍ J. Rosenstock; S. Sankoh; J. F. List 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Dipeptidyl peptidase-4 inhibitors in the

✍ C. F. Deacon 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB

Dipeptidyl Peptidase IV Inhibitors for t

✍ Ann E. Weber 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 10 KB 👁 1 views

Erratum to: Saxagliptin: a New DPP-4 inh

✍ Abd A. Tahrani; Milan K. Piya; Anthony H. Barnett 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 99 KB

Optimization of 1,4-Diazepan-2-one-Conta

✍ Gui-Bai Liang; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 24 KB 👁 1 views